FindTrial
Sign In

Evaluating the diagnostic types of thrombotic microangiopathy (TMA) disorder to create a TMA registry in our population

Laboratory Evaluation of Clinically Suspected Thrombotic Microangiopathy Cases and to Develop a Regional Registry for Thrombotic Microangiopathy - TMA Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054550
Enrollment
70
Registered
2023-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D688- Other specified coagulation defects

Interventions

Intervention1: NIL: not applicable

Sponsors

MAHE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical suspicion of TMA 2.This study will cover all age groups.

Exclusion criteria

Exclusion criteria: 1.Patients with known history thrombotic disorder or thrombophilia. 2.Patients who are on anticoagulants and anti platelets.

Design outcomes

Primary

MeasureTime frame
All patients with clinical suspicion of TMA and undergo testing will be included in the study and only those who turn out to be positive for TMA panel will be included for the registryTimepoint: 4 weeks—

Secondary

MeasureTime frame
i.Generate a tool to predict the clinical severity ii.Developing registry for TMA cases which might be useful in National scenario in such rare hematological disorders iii.Once the data is analyzed, we will be able to propose a decision tree algorithm for diagnosing suspected TMA cases Timepoint: 3—

Countries

India

Contacts

Public ContactRiya

Kasturba Medical College

shameeshastry@gmail.com9743493364

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026